ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,150Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 1000

$1.03M Total Retail Price of All Prescriptions

Rank: 42 out of 1000

946 Patients Receiving at Least One Drug in Part D
41%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 946 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

49% of this provider’s 946 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

4% of this provider’s 11,939 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 3,182 764 S3 1 1
FUROSEMIDE 1,027 583 2 7
OMEPRAZOLE 879 378 3 2
MELOXICAM 844 353 4 14
SIMVASTATIN 695 362 5 3
POTASSIUM CHLORIDE 658 398 6 10
AMLODIPINE BESYLATE 616 315 7 6
CEPHALEXIN 571 235 8 90
LISINOPRIL 548 260 9 5
CARISOPRODOL 517 51 R 10 72
ZOLPIDEM TARTRATE 513 147 11 16
CLONIDINE HCL 504 239 12 27
METOPROLOL TARTRATE 448 269 13 19
KLOR-CON 10 447 232 10 14 104
ALLOPURINOL 397 264 15 31
CARVEDILOL 350 159 16 15
LEVOTHYROXINE SODIUM 307 152 17 4
BISOPROLOL-HYDROCHLOROTHIAZIDE 283 110 18 101
TIZANIDINE HCL 268 63 19 76
HYDROCHLOROTHIAZIDE 267 118 20 9
METFORMIN HCL 265 157 21 8
GLIPIZIDE 259 164 22 62
AMITRIPTYLINE HCL 258 109 R 23 45
ROPINIROLE HCL 256 103 24 82
AZITHROMYCIN 230 84 25 36
TRAMADOL HCL 223 132 26 13
GABAPENTIN 219 58 27 11
CYCLOBENZAPRINE HCL 208 30 R 28 39
NEXIUM 207 82 29 23
SULFAMETHOXAZOLE-TRIMETHOPRIM 207 80 29 70
HYDRALAZINE HCL 187 120 31 74
IBUPROFEN 187 49 31 94
GLYBURIDE-METFORMIN HCL 178 64 R 33 121
PRAVASTATIN SODIUM 176 97 34 12
LOSARTAN POTASSIUM 171 93 35 25
ATENOLOL 168 99 36 24
RANITIDINE HCL 165 70 37 37
TAMSULOSIN HCL 162 124 38 33
KLOR-CON M20 162 104 38 66
LISINOPRIL-HYDROCHLOROTHIAZIDE 154 77 40 20
CIPROFLOXACIN HCL 153 58 41 46
AMLODIPINE BESYLATE-BENAZEPRIL 150 69 42 59
INSULIN SYRINGE 146 80 43 93
PROMETHAZINE HCL 140 23 R 44 54
PREMARIN 137 0 R 45 109
GLIPIZIDE ER 133 53 46 106
ESTRADIOL 130 25 R 47 114
PANTOPRAZOLE SODIUM 125 71 48 28
FLUCONAZOLE 125 17 48 102
METOLAZONE 123 55 50 167
FLUOXETINE HCL 121 43 51 51
METOPROLOL SUCCINATE 120 62 52 21
OXYCODONE HCL 117 40 S2 53 118
OXYCODONE HCL-ACETAMINOPHEN 115 33 S2 54 138
HUMULIN 70-30 114 71 55 131
CLOPIDOGREL 112 64 56 35
FLUTICASONE PROPIONATE 111 29 57 40
GLYBURIDE 109 70 R 58 92
ESCITALOPRAM OXALATE 106 58 59 60
PREDNISONE 104 39 60 42
PHENYTOIN SODIUM EXTENDED 104 23 60 115
LOSARTAN-HYDROCHLOROTHIAZIDE 103 29 62 38
TRIAMCINOLONE ACETONIDE 103 42 62 159
CYMBALTA 99 26 64 53
LYRICA 98 27 65 47
WARFARIN SODIUM 94 77 66 22
PLAVIX 91 55 67 49
NAPROXEN 89 43 68 81
ISOSORBIDE MONONITRATE ER 87 50 69 71
FENTANYL 85 26 S2 70 100
VERAPAMIL ER 85 38 70 86
METHADONE HCL 84 0 S2 72 161
PROAIR HFA 84 36 72 50
ENDOCET 83 0 S2 74 107
FAMOTIDINE 82 35 75 88
CLOTRIMAZOLE-BETAMETHASONE 81 28 76 173
ENALAPRIL MALEATE 79 51 77 58
LANTUS 77 37 78 68
COLCRYS 76 54 79 171
GLIPIZIDE XL 76 34 79 138
DIVALPROEX SODIUM 75 32 81 113
AMPHETAMINE SALT COMBO 75 0 S2 81 223
ATORVASTATIN CALCIUM 74 44 83 18
METRONIDAZOLE 72 12 84 281
NYSTATIN-TRIAMCINOLONE 70 26 85 255
SINGULAIR 70 33 85 84
ADVAIR DISKUS 69 36 87 65
AMOXICILLIN 69 16 87 89
AMIODARONE HCL 68 57 89 178
HYDROMORPHONE HCL 67 0 S2 90 311
DONEPEZIL HCL 66 66 91 32
SUCRALFATE 65 59 92 144
DIGOXIN 65 57 92 52
ACETAMINOPHEN-CODEINE 63 29 S3 94 127
MONTELUKAST SODIUM 63 32 94 132
CYPROHEPTADINE HCL 62 23 R 96 297
QUETIAPINE FUMARATE 60 0 97 75
HYDROXYZINE HCL 59 35 R 98 153
SERTRALINE HCL 59 23 98 26
LOVASTATIN 59 26 98 41
THEOPHYLLINE ANHYDROUS 59 53 98 186
LIDODERM 58 0 102 220
DICLOFENAC SODIUM 57 34 103 123
CRESTOR 57 20 103 30
DIOVAN 57 40 103 67
POLYETHYLENE GLYCOL 3350 56 19 106 69
SYMBICORT 56 19 106 149
CELEBREX 56 25 106 98
SUMATRIPTAN SUCCINATE 55 14 109 282
BENAZEPRIL HCL 54 20 110 61
BENICAR HCT 54 27 110 262
KETOCONAZOLE 54 19 110 219
DOXYCYCLINE HYCLATE 53 0 113 97
NIFEDIPINE ER 53 32 113 130
TRAZODONE HCL 52 31 115 29
DIOVAN HCT 52 22 115 96
METFORMIN HCL ER 52 33 115 44
MECLIZINE HCL 51 42 118 80
TRIAMTERENE-HCTZ 50 0 119 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 30, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.